Related references
Note: Only part of the references are listed.Estimates of cancer incidence and mortality in Europe in 2008
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2010)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers
Natalie Jeffery et al.
HISTOPATHOLOGY (2009)
Matrix Metalloproteinases As Novel Biomarkers and Potential Therapeutic Targets in Human Cancer
Roopali Roy et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Lack of prognostic value of MMP-9 expression and immunohistochemically defined germinal center phenotype in patients with diffuse large B-cell lymphoma treated with modern chemotherapy with or without CD20 antibody
Heli Kyllonen et al.
LEUKEMIA & LYMPHOMA (2009)
Prognostic Value of Tumor-Related Molecular Expression in Gastric Carcinoma
Zhong-Sheng Zhao et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer
Yang Tang et al.
CLINICAL CANCER RESEARCH (2008)
Prognostic significance of matrix metalloproteinases-1,-2,-7 and-13 and tissue inhibitors of metalloproteinases-1,-2,-3 and-4 in colorectal cancer
Marja Hilska et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution
Chun-Ying Wu et al.
CLINICAL CANCER RESEARCH (2007)
Pro-MMP-9 is associated with poor prognosis in gastric cancer
Yukihiro Nomura et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2007)
MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer
J. Mrena et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Profiling markers of prognosis in colorectal cancer
MS Lyall et al.
CLINICAL CANCER RESEARCH (2006)
Incidence and mortality of gastric cancer in China
Ling Yang
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Enhanced radiosensitization and chemosensitization in NF-κB-suppressed human oral cancer cells via the inhibition of γ-irradiation- and 5-Fu-induced production,of Il-6 and Il-8
T Tamatani et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers
S Curran et al.
CLINICAL CANCER RESEARCH (2004)
Disulfiram-mediated inhibition of NF-κB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines
WG Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer
MF Leeman et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Helicobacter pylori and gastrointestinal tract adenocarcinomas
RM Peek et al.
NATURE REVIEWS CANCER (2002)
Development of matrix metalloproteinase inhibitors in cancer therapy
M Hidalgo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis
S Curran et al.
EUROPEAN JOURNAL OF CANCER (2000)
Identification and characterization of human endometase (matrix metalloproteinase-26) from endometrial tumor
HI Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems
A Rhodes et al.
JOURNAL OF CLINICAL PATHOLOGY (2000)